Indication

Streptococcal toxic shock syndrome

Streptococcal toxic shock syndrome is a severe, life-threatening complication of invasive infection primarily caused by *Streptococcus pyogenes* (group A *Streptococcus*). Read more about Streptococcal toxic shock syndrome

15 drugs 12 manufacturers

Advertisement

Drugs that treat it

Common Streptococcal toxic shock syndrome therapies.

Showing 1–9 of 15 drugs

Filter & compare in the drug finder →Opens the drug finder with Streptococcal toxic shock syndrome preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Streptococcal toxic shock syndrome.

Streptococcal toxic shock syndrome is a severe, life-threatening complication of invasive infection primarily caused by *Streptococcus pyogenes* (group A *Streptococcus*).

It affects systemic hemodynamics and multiple organ systems, most frequently manifesting in adults with soft tissue or surgical site infections, though it can occur in individuals of any age.

Pathophysiologically, the syndrome is driven by bacterial pyrogenic exotoxins that function as superantigens, triggering widespread T-cell activation and a massive cytokine cascade.

Clinically, it is characterized by the rapid onset of profound hypotension and multiorgan failure—including renal impairment, coagulopathy, hepatic injury, and acute respiratory distress syndrome—often accompanied by soft tissue necrosis and severe systemic toxicity.

Personalize your experience

Follow Streptococcal toxic shock syndrome and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it